314 related articles for article (PubMed ID: 15655144)
1. Prevalence of neurofibromatosis 1 in German children at elementary school enrollment.
Lammert M; Friedman JM; Kluwe L; Mautner VF
Arch Dermatol; 2005 Jan; 141(1):71-4. PubMed ID: 15655144
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of café au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1.
Nunley KS; Gao F; Albers AC; Bayliss SJ; Gutmann DH
Arch Dermatol; 2009 Aug; 145(8):883-7. PubMed ID: 19687418
[TBL] [Abstract][Full Text] [Related]
3. [Neurofibromatosis in children. Our experience].
López-Pisón J; Cuadrado-Martín M; Boldova-Aguar MC; Muñoz-Mellado A; Cabrerizo de Diago R; Peña-Segura JL
Rev Neurol; 2003 Nov 1-15; 37(9):820-5. PubMed ID: 14606048
[TBL] [Abstract][Full Text] [Related]
4. [Managing children with neurofibromatosis type 1: what should we look for?].
Martins CL; Monteiro JP; Farias A; Fernandes R; Fonseca MJ
Acta Med Port; 2007; 20(5):393-400. PubMed ID: 18282435
[TBL] [Abstract][Full Text] [Related]
5. Café-au-lait Macules and Neurofibromatosis Type 1: A Review of the Literature.
Bernier A; Larbrisseau A; Perreault S
Pediatr Neurol; 2016 Jul; 60():24-29.e1. PubMed ID: 27212418
[TBL] [Abstract][Full Text] [Related]
6. Café-au-lait spots in neurofibromatosis type 1 and in healthy control individuals: hyperpigmentation of a different kind?
De Schepper S; Boucneau J; Vander Haeghen Y; Messiaen L; Naeyaert JM; Lambert J
Arch Dermatol Res; 2006 Apr; 297(10):439-49. PubMed ID: 16479403
[TBL] [Abstract][Full Text] [Related]
7. [Segmental neurofibromatosis in children. Presentation of 43 patients].
Pascual-Castroviejo I; Pascual-Pascual SI; Velázquez-Fragua R; Viaño J; López-Gutiérrez JC
Rev Neurol; 2008 Oct 16-31; 47(8):399-403. PubMed ID: 18937200
[TBL] [Abstract][Full Text] [Related]
8. Giant café-au-lait macule in neurofibromatosis 1: a type 2 segmental manifestation of neurofibromatosis 1?
Yang CC; Happle R; Chao SC; Yu-Yun Lee J; Chen W
J Am Acad Dermatol; 2008 Mar; 58(3):493-7. PubMed ID: 18280349
[TBL] [Abstract][Full Text] [Related]
9. [Pheochromocytoma associated with neurofibromatosis 1: a report of two cases].
Sano F; Fujikawa N; Hirai K; Ueki T; Kitami K
Hinyokika Kiyo; 2005 Dec; 51(12):793-5. PubMed ID: 16440725
[TBL] [Abstract][Full Text] [Related]
10. [Neurofibromatosis].
Wolkenstein P; Decq P
Neurochirurgie; 1998 Nov; 44(4):267-72. PubMed ID: 9864698
[TBL] [Abstract][Full Text] [Related]
11. [Neurofibromatosis type 1: a survey of 195 patients].
Overweg-Plandsoen WC; Weersink RG; Sillevis Smitt JH; Fleury P; van Asperen CJ
Ned Tijdschr Geneeskd; 1997 Mar; 141(13):624-9. PubMed ID: 9127578
[TBL] [Abstract][Full Text] [Related]
12. Predicting neurofibromatosis type 1 risk among children with isolated café-au-lait macules.
Ben-Shachar S; Dubov T; Toledano-Alhadef H; Mashiah J; Sprecher E; Constantini S; Leshno M; Messiaen LM
J Am Acad Dermatol; 2017 Jun; 76(6):1077-1083.e3. PubMed ID: 28318682
[TBL] [Abstract][Full Text] [Related]
13. Analysis of intrafamilial phenotypic variation in neurofibromatosis 1 (NF1).
Szudek J; Joe H; Friedman JM
Genet Epidemiol; 2002 Aug; 23(2):150-64. PubMed ID: 12214308
[TBL] [Abstract][Full Text] [Related]
14. Genetic and clinical considerations in six cases with neurofibromatosis type 1.
Buteică E; Stoicescu I; Burada F; Stănoiu B
Rom J Morphol Embryol; 2007; 48(3):243-8. PubMed ID: 17914490
[TBL] [Abstract][Full Text] [Related]
15. [Neurofibromatosis type 1 in children. Experiences of the Gdansk Paediatric Oncohaematology Centre. Preliminary results].
Sierota D; Stefanowicz J; Wierzba J; Adamkiewicz-Drozyńska E; Wybieralska-Dubaniewicz M; Kosiak W; Komasara L; Czauderna P; Izycka-Swieszewska E; Pilarska E; Birkholtz D; Stachowicz-Stencel T; Połczyńska K; Bień E; Szołkiewicz A; Stefanowicz A; Balcerska A
Med Wieku Rozwoj; 2007; 11(3 Pt 2):307-12. PubMed ID: 18663272
[TBL] [Abstract][Full Text] [Related]
16. Eye disorders in neurofibromatosis (NF1).
Kordić R; Sabol Z; Cerovski B; Katusić D; Jukić T
Coll Antropol; 2005; 29 Suppl 1():29-31. PubMed ID: 16193672
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of neurofibromatosis type 1.
Friedman JM
Am J Med Genet; 1999 Mar; 89(1):1-6. PubMed ID: 10469430
[TBL] [Abstract][Full Text] [Related]
18. SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype.
Pasmant E; Sabbagh A; Hanna N; Masliah-Planchon J; Jolly E; Goussard P; Ballerini P; Cartault F; Barbarot S; Landman-Parker J; Soufir N; Parfait B; Vidaud M; Wolkenstein P; Vidaud D; France RN
J Med Genet; 2009 Jul; 46(7):425-30. PubMed ID: 19366998
[TBL] [Abstract][Full Text] [Related]
19. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.
Hyman SL; Shores A; North KN
Neurology; 2005 Oct; 65(7):1037-44. PubMed ID: 16217056
[TBL] [Abstract][Full Text] [Related]
20. Early grade repetition and inattention associated with neurofibromatosis type 1.
Coudé FX; Mignot C; Lyonnet S; Munnich A
J Atten Disord; 2007 Sep; 11(2):101-5. PubMed ID: 17494836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]